Overview: Methylmalonic Acid Quantitative TestIntroduction: The Methylmalonic Acid Quantitative Test measures methylmalonic acid to diagnose vitamin B12 deficiency, causing anemia or fatigue. Aligned with 2023 ASH guidelines, it uses biochemistry methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected vitamin B12 deficiency.
Other Names: MMA Quantitative Assay, B12 Deficiency Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Quantitative MMA testing began in the 1970s with metabolic research. Analytical methods improved in the 2000s, enhancing detection sensitivity.
Purpose: Measures methylmalonic acid to diagnose vitamin B12 deficiency, guides treatment, and evaluates patients with anemia or fatigue.
Test Parameters: 1. Methylmalonic Acid (Quantitative)
Pretest Condition: No fasting required. Collect serum, plasma, or urine. Report history of anemia, fatigue, or neurological symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document anemia, fatigue, neurological symptoms, or history of dietary deficiencies. Include current medications, especially metformin.
Consent: Written consent required, detailing the tests purpose, vitamin B12 deficiency implications, and risks of sample collection.
Procedural Considerations: Uses biochemistry methods (e.g., liquid chromatography-mass spectrometry) to measure methylmalonic acid in specimens. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for vitamin B12 deficiency diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Sample quality impacts sensitivity.
Clinical Significance: Elevated methylmalonic acid confirms vitamin B12 deficiency, guiding supplementation. Normal levels may require further metabolic testing.
Specialist Consultation: Consult a hematologist or primary care physician for result interpretation and treatment planning.
Additional Supporting Tests: Serum B12, homocysteine, or folate levels to confirm vitamin B12 deficiency diagnosis.
Test Limitations: May miss early deficiencies; clinical correlation is needed. Renal dysfunction may elevate levels.
References: ASH B12 Deficiency Guidelines, 2023; Blood, Carmel R, 2022.
